Skip to main content
Clinical Trials/NCT01629407
NCT01629407
Completed
Not Applicable

A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

Allergan0 sites315 target enrollmentJune 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma, Open-Angle
Sponsor
Allergan
Enrollment
315
Primary Endpoint
Change from Baseline in Visual Field
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
May 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Allergan
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Glaucoma in one or both eyes

Exclusion Criteria

  • Participation in a glaucoma therapeutic clinical trial

Outcomes

Primary Outcomes

Change from Baseline in Visual Field

Time Frame: Baseline, 24 Months

Secondary Outcomes

  • Change from Baseline in Intraocular Pressure (IOP)(Baseline, 24 Months)

Similar Trials